Neuroinflammation is a well-established feature of PD, and a growing body of evidence suggests that both peripheral and central immune dysregulation can upregulate cytokines such as IL-1β, IL-6, and TNF-α [88], which participate in the development and persistence of pain states during PD. Here, IL1B is linked to Parkinson disease.